| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/13/1998 | US5708138 Immunoreactive peptides of apo(a) |
| 01/13/1998 | US5707969 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/13/1998 | US5707863 Tumor suppressor gene merlin |
| 01/13/1998 | US5707862 Shuttle vector |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707817 Tyvelose joined to glycosides linkages |
| 01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
| 01/13/1998 | US5707629 Immunogenic composition against equine herpesvirus type 1 |
| 01/13/1998 | US5707627 Methods and compositions for the direct concentrated delivery of passive immunity |
| 01/13/1998 | US5707626 Methods of treating HIV infection using antibodies to the U2 small nuclear ribonuclear protein |
| 01/13/1998 | US5707622 Methods for treating ulcerative colitis |
| 01/13/1998 | US5707617 Cultures used for immunoassay to detect infections, preparation of vaccines |
| 01/13/1998 | US5707616 Method for treating or preventing gastrointestinal disease with epithelium-derived T-cell factor |
| 01/08/1998 | WO1998000552A2 Receptor tyrosine phosphatase, and uses related thereto |
| 01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 01/08/1998 | WO1998000536A1 Immunocontraceptive methods and peptide or polypeptides for use in these methods |
| 01/08/1998 | WO1998000531A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | WO1998000444A1 Vaccine against carbohydrate antigens |
| 01/08/1998 | WO1998000440A1 Immunocontraceptive compositions containing sperm antigens, and methods of use |
| 01/08/1998 | WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | WO1998000174A2 Method of preparing a composite bone graft |
| 01/08/1998 | WO1998000167A1 Multivalent dtp-polio vaccines |
| 01/08/1998 | WO1998000166A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 01/08/1998 | WO1998000165A1 Porcine reproductive and respiratory syndrome vaccine |
| 01/08/1998 | WO1998000164A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor |
| 01/08/1998 | WO1998000163A1 INDUCTION OF CTLs SPECIFIC FOR NATURAL ANTIGENS BY CROSS-PRIMING IMMUNIZATION |
| 01/08/1998 | WO1998000162A1 Complex comprising antigen and cell constituent, method of preparing said complex and its therapeutic uses |
| 01/08/1998 | WO1997046255A3 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997039020A3 Antigenic sequences of a sperm protein and immunocontraceptive methods |
| 01/08/1998 | DE19626830A1 Konditionales Immortalisationsverfahren für humane Tumorzellen zur Herstellung einer Vakzine Conditional Immortalisationsverfahren for human tumor cells to produce a vaccine |
| 01/08/1998 | DE19626614A1 Komplex aus Antigen und Zellbestandteil, Impfstoffzusammensetzung, welche den Komplex enthält, pharmazeutische Präparation sowie Verfahren zur Herstellung des Komplexes Complex of antigen and cell component vaccine composition containing the complex, pharmaceutical preparation, and methods for preparation of the complex |
| 01/08/1998 | CA2259415A1 Multivalent dtp-polio vaccines |
| 01/08/1998 | CA2259237A1 Immunocontrapceptive methods and peptide or polypeptides for use in these methods |
| 01/08/1998 | CA2259147A1 Immunocontraceptive compositions containing sperm antigens, and methods of use |
| 01/08/1998 | CA2258840A1 Induction of ctls specific for natural antigens by cross-priming immunization |
| 01/08/1998 | CA2258717A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor |
| 01/08/1998 | CA2258286A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/07/1998 | EP0816506A1 System for the expression of heterologous antigens as fusion proteins |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816496A2 T-cells specific for kidney carcinoma |
| 01/07/1998 | EP0815872A2 Compounds for targeting |
| 01/07/1998 | EP0815868A1 A chinese drug composition for treatment of peptic ulcer and preparation thereof |
| 01/07/1998 | EP0815852A1 A method for high loading of vesicles with biopolymeric substances |
| 01/07/1998 | EP0815450A2 Compounds and methods for the dectection of t. cruzi infection |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815236A1 Haemophilus adhesion proteins |
| 01/07/1998 | EP0815235A1 Vaccines for plague |
| 01/07/1998 | EP0815234A1 Proteinase k resistant surface protein of neisseria meningitidis |
| 01/07/1998 | EP0815233A1 Novel avian cytokines and genetic sequences encoding same |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815229A2 Rage tumor rejection antigens |
| 01/07/1998 | EP0815227A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF |
| 01/07/1998 | EP0815223A1 Dermatomyositis-specific auto-antigen |
| 01/07/1998 | EP0815220A1 Human amine transporter |
| 01/07/1998 | EP0815204A1 Method for treating tumors |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815199A1 Human deoxycytidine kinase 2 |
| 01/07/1998 | EP0815142A1 Antigen composition against mycoplasma |
| 01/07/1998 | EP0815141A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 01/07/1998 | EP0815137A1 Human g-protein chemokine receptor hdgnr10 |
| 01/07/1998 | EP0815134A1 Modulators of amyloid aggregation |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815118A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0814837A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/07/1998 | EP0814836A1 Vaccine adjuvants |
| 01/07/1998 | EP0814835A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition |
| 01/07/1998 | EP0814834A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 01/07/1998 | EP0814833A1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814829A1 Method for enhancing the antibody response to specific antigens with interleukin-10 |
| 01/07/1998 | EP0814827A1 Vascular endothelial growth factor-b |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0682529B1 Antibody for the treatment of insulin dependent diabetes |
| 01/07/1998 | EP0581882B1 Process of screening plasma samples for effective antibody titers against respiratory viruses |
| 01/07/1998 | EP0554414B1 Method for producing a subunit vaccine against the canine parvovirus and other related viruses |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | EP0486572B1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 01/07/1998 | EP0447424B1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 01/07/1998 | CN1169754A Human interleudin-1 receptor accessory Protein |
| 01/07/1998 | CN1169735A CD 23 binding agent |
| 01/07/1998 | CN1169317A Blood vessel endothelial factor and antagonist thereof |
| 01/06/1998 | US5705626 Polypeptide for aids therapy |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705612 NEF peptide encoded by human immunodefiency virus type 1 (HIV-1) |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705367 Neisseria having reading frames |
| 01/06/1998 | US5705361 Hybrid transposon with PT operon, plasmids and bacterial strains therefor |
| 01/06/1998 | US5705359 Expression of heterologous proteins in drosophila cells |
| 01/06/1998 | US5705197 Extraction process for producing PLGA microspheres |
| 01/06/1998 | US5705161 Immunogenic meningococcal LPS and other membrane vesicles and vaccine therefrom |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |